Bank Pictet & Cie (Europe)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,772
Closed -$245K 171
2024
Q3
$245K Sell
5,772
-4,644
-45% -$197K 0.01% 142
2024
Q2
$420K Sell
10,416
-5,498
-35% -$229K 0.01% 127
2024
Q1
$564K Buy
15,914
+104
+0.7% +$2.79K 0.01% 127
2023
Q4
$468K Buy
+15,810
New +$328K 0.01% 193
2023
Q2
Sell
-6,377
Closed -$259K 282
2023
Q1
$259K Buy
+6,377
New +$264K 0.01% 159
2022
Q1
Sell
-5,528
Closed -$832K 187
2021
Q4
$832K Buy
5,528
+610
+12% +$82.3K 0.03% 110
2021
Q3
$587K Sell
4,918
-473
-9% -$52.1K 0.02% 124
2021
Q2
$525K Buy
5,391
+791
+17% +$70.5K 0.02% 135
2021
Q1
$406K Buy
+4,600
New +$428K 0.02% 131

Other funds holding TNDM

Bank Pictet & Cie (Europe)'s TNDM Position: Q4 2024 in Review

Bank Pictet & Cie (Europe) sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 5,772 shares — an estimated $245K sold.

Bank Pictet & Cie (Europe) first reported a position in TNDM in Q1 2021 and held it in 9 quarters. The position peaked at $832K in Q4 2021. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Bank Pictet & Cie (Europe) reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 5,772 Tandem Diabetes Care shares in Q4 2024, an estimated $245K.
  • Bank Pictet & Cie (Europe) first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 9 quarters.
  • Bank Pictet & Cie (Europe)'s Tandem Diabetes Care position peaked at $832K in Q4 2021.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2024, filed 30 Jan 2025.